Clinical Trial Update: A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer [Phase 3]

View source ↗

Summary

This clinical trial evaluated bevacizumab in combination with chemotherapy for patients with previously treated breast cancer; the Phase 3 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED